Table 1:
Model | Effect size and 95% interval | Test of null (2-Tail) | Heterogeneity | |||||||
---|---|---|---|---|---|---|---|---|---|---|
Number Studies | Prevalence | Lower limit | Upper limit | Z-value | P-value | Q-value | df (Q) | P-value | I-squared | |
Ampicilin | 17 | 0.9828 | 0.9652 | 0.9915 | 11.01 | <0.001 | 263.91 | 16 | <0.001 | 93.93 |
Penicilin | 24 | 0.9897 | 0.9773 | 0.9954 | 11.08 | <0.001 | 688.71 | 23 | <0.001 | 96.66 |
Vancomycin | 17 | 0.9977 | 0.9921 | 0.9993 | 9.58 | <0.001 | 184.53 | 16 | <0.001 | 91.32 |
Erythromycin | 16 | 0.8096 | 0.6476 | 0.9077 | 3.38 | 0.001 | 3635.97 | 15 | <0.001 | 99.58 |
Clindamycin | 13 | 0.7590 | 0.6180 | 0.8597 | 3.37 | 0.001 | 1738.60 | 12 | <0.001 | 99.30 |